Literature DB >> 9015465

Ophthalmic complications of HIV/AIDS.

F G Ah-Fat1, M Batterbury.   

Abstract

As a result of improved treatment and patient survival, ophthalmic complications are now being seen with increasing frequency in AIDS, occurring in up to 75% of patients during the course of the disease. The eye may be involved by an AIDS-related microvasculopathy, which gives rise to cotton wool spots, and by opportunistic infections caused by a wide range of organisms, including cytomegalovirus, herpes simplex virus, varicella zoster, Toxoplasma gondii, Mycobacterium avium-intracellulare, Treponema pallidum, Pneumocystis carinii and various fungal agents. Opportunistic infections may be the presenting sign of disseminated infection. The eye may also be involved by neoplasms such as Kaposi's sarcoma and lymphoma, and by intracranial disease. Ocular involvement may lead to blindness if untreated and prompt ophthalmological referral is essential. This article reviews the range of ocular diseases seen in HIV and AIDS, current therapeutic options and outcome.

Entities:  

Mesh:

Year:  1996        PMID: 9015465      PMCID: PMC2398675          DOI: 10.1136/pgmj.72.854.725

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  28 in total

Review 1.  Noninfectious ocular complications of AIDS.

Authors:  D A Newsome
Journal:  Int Ophthalmol Clin       Date:  1989

2.  Treatment of cytomegalovirus retinopathy with ganciclovir.

Authors:  G N Holland; Y Sidikaro; A E Kreiger; D Hardy; M J Sakamoto; L M Frenkel; D J Winston; M S Gottlieb; Y J Bryson; R E Champlin
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

3.  Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease.

Authors:  J S Pepose; G N Holland; M S Nestor; A J Cochran; R Y Foos
Journal:  Ophthalmology       Date:  1985-04       Impact factor: 12.079

Review 4.  Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.

Authors:  R M Levy; D E Bredesen; M L Rosenblum
Journal:  J Neurosurg       Date:  1985-04       Impact factor: 5.115

5.  Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome.

Authors:  G N Holland; R E Engstrom; B J Glasgow; B B Berger; S A Daniels; Y Sidikaro; J A Harmon; D H Fischer; D S Boyer; N A Rao
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

6.  Ophthalmologic findings in acquired immune deficiency syndrome (AIDS).

Authors:  M Khadem; S B Kalish; J Goldsmith; C Fetkenhour; R B O'Grady; J P Phair; M Chrobak
Journal:  Arch Ophthalmol       Date:  1984-02

7.  Demonstration of herpes group virus in acute retinal necrosis syndrome.

Authors:  W R Freeman; E L Thomas; N A Rao; J S Pepose; M D Trousdale; E L Howes; A J Nadel; J A Mines; B Bowe
Journal:  Am J Ophthalmol       Date:  1986-12-15       Impact factor: 5.258

8.  Herpes zoster ophthalmicus and acquired immune deficiency syndrome.

Authors:  E L Cole; D M Meisler; L H Calabrese; G N Holland; B J Mondino; M A Conant
Journal:  Arch Ophthalmol       Date:  1984-07

9.  Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome.

Authors:  A Macher; M M Rodrigues; W Kaplan; M C Pistole; A McKittrick; W E Lawrinson; C M Reichert
Journal:  Ophthalmology       Date:  1985-08       Impact factor: 12.079

10.  Acquired immune deficiency syndrome. Ocular manifestations.

Authors:  G N Holland; J S Pepose; T H Pettit; M S Gottlieb; R D Yee; R Y Foos
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

View more
  2 in total

1.  Ophthalmic complications of HIV/AIDS.

Authors:  A Vaghjimal
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

2.  Orbital tuberculosis manifesting as proptosis in an immunocompromised host.

Authors:  Shashank Banait; Jyoti Jain; P H Parihar; Vikas Karwassara
Journal:  Indian J Sex Transm Dis AIDS       Date:  2012-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.